MetaCap

Scinai Immunotherapeutics (SCNI) News

NASDAQ: SCNIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.58+0.0258 (+1.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SCNI news summary

We found 2 recent headlines mentioning Scinai Immunotherapeutics (SCNI): 0 in the past week and 1 in the past 30 days, most often from PR Newswire. For price context, SCNI is up 1.66% at $1.58. The most recent story, "Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands", was published by PR Newswire on Nov 5, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Scinai Immunotherapeutics headlines

Compare SCNI